Login
Home
Charts
Search
Watchlist
Products

Brawn Biotech Ltd

BRAWN·BSE
₹22.05+1.80%Tue, 22 Sept '26
Industry:Trading
Indices:

Brawn Biotech Ltd

BRAWN
BSE
₹22.05
+1.80%
|Tue, 22 Sept '26
SOICxStockScans Reports
Industry
Trading
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹7Cr
Close
Close Price
₹22.05
Industry
Industry
Trading
PE
Price To Earnings
7.63
PS
Price To Sales
0.38
Revenue
Revenue
₹17Cr
Rev Gr TTM
Revenue Growth TTM
13.55%
PAT Gr TTM
PAT Growth TTM
183.33%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
333434265426
Growth YoY
Revenue Growth YoY%
-62.4-55.0-27.4-44.313.035.2-34.542.948.212.2-12.44.8
Expenses
ExpensesCr
334544365426
Operating Profit
Operating ProfitCr
0-10-100-1000-10
OPM
OPM%
-13.4-20.4-11.3-12.3-9.4-10.7-24.33.10.2-0.2-25.30.8
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
0-10-100000000
Tax
TaxCr
0000000000-10
PAT
PATCr
0-10-100000010
Growth YoY
PAT Growth YoY%
-20.0-1,425.044.3-211.819.129.5-44.1145.3120.6111.6218.4-37.5
NPM
NPM%
-14.4-21.5-9.9-13.1-10.3-11.2-21.74.11.41.229.32.5
EPS
EPS₹
-1.4-2.0-1.1-1.8-1.0-1.4-1.60.90.30.21.90.5
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
333434265426
Growth YoY
Revenue Growth YoY%
-62.4-55.0-27.4-44.313.035.2-34.542.948.212.2-12.44.8
Expenses
ExpensesCr
334544365426
Operating Profit
Operating ProfitCr
0-10-100-1000-10
OPM
OPM%
-13.4-20.4-11.3-12.3-9.4-10.7-24.33.10.2-0.2-25.30.8
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
0-10-100000000
Tax
TaxCr
0000000000-10
PAT
PATCr
0-10-100000010
Growth YoY
PAT Growth YoY%
-20.0-1,425.044.3-211.819.129.5-44.1145.3120.6111.6218.4-37.5
NPM
NPM%
-14.4-21.5-9.9-13.1-10.3-11.2-21.74.11.41.229.32.5
EPS
EPS₹
-1.4-2.0-1.1-1.8-1.0-1.4-1.60.90.30.21.90.5

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
47615665503592216131717
Growth
Revenue Growth%
21.329.1-7.916.8-23.9-29.5-75.3157.9-25.8-18.426.113.6
Expenses
ExpensesCr
455954644936112318151718
Operating Profit
Operating ProfitCr
11211-1-20-2-200
OPM
OPM%
3.02.03.51.81.5-1.7-23.3-1.4-9.3-13.2-1.9-2.6
Other Income
Other IncomeCr
010100000001
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
122210-20-2-200
Tax
TaxCr
0010000000-1-1
PAT
PATCr
11111-1-2-1-1-211
Growth
PAT Growth%
234.146.7-8.04.0-55.6-193.1-198.747.2-43.6-39.5154.1183.3
NPM
NPM%
2.02.32.32.01.2-1.6-19.1-3.9-7.6-12.95.54.9
EPS
EPS₹
3.24.64.24.62.0-1.6-5.3-3.0-5.1-5.93.32.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
47615665503592216131717
Growth
Revenue Growth%
21.329.1-7.916.8-23.9-29.5-75.3157.9-25.8-18.426.113.6
Expenses
ExpensesCr
455954644936112318151718
Operating Profit
Operating ProfitCr
11211-1-20-2-200
OPM
OPM%
3.02.03.51.81.5-1.7-23.3-1.4-9.3-13.2-1.9-2.6
Other Income
Other IncomeCr
010100000001
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
122210-20-2-200
Tax
TaxCr
0010000000-1-1
PAT
PATCr
11111-1-2-1-1-211
Growth
PAT Growth%
234.146.7-8.04.0-55.6-193.1-198.747.2-43.6-39.5154.1183.3
NPM
NPM%
2.02.32.32.01.2-1.6-19.1-3.9-7.6-12.95.54.9
EPS
EPS₹
3.24.64.24.62.0-1.6-5.3-3.0-5.1-5.93.32.9

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
33333333333
Reserves
ReservesCr
34566643201
Current Liabilities
Current LiabilitiesCr
8101514115687915
Non Current Liabilities
Non Current LiabilitiesCr
00000000381
Total Liabilities
Total LiabilitiesCr
1417232320141415152021
Current Assets
Current AssetsCr
1117222219131213131817
Non Current Assets
Non Current AssetsCr
30111121134
Total Assets
Total AssetsCr
1417232320141415152021
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
33333333333
Reserves
ReservesCr
34566643201
Current Liabilities
Current LiabilitiesCr
8101514115687915
Non Current Liabilities
Non Current LiabilitiesCr
00000000381
Total Liabilities
Total LiabilitiesCr
1417232320141415152021
Current Assets
Current AssetsCr
1117222219131213131817
Non Current Assets
Non Current AssetsCr
30111121134
Total Assets
Total AssetsCr
1417232320141415152021

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
01-200000001
Investing Cash Flow
Investing Cash FlowCr
01000000000
Financing Cash Flow
Financing Cash FlowCr
00000000000
Net Cash Flow
Net Cash FlowCr
02-200000001
Free Cash Flow
Free Cash FlowCr
01-200000001
CFO To PAT
CFO To PAT%
5.598.2-120.415.8-12.9-6.0-11.4-36.62.1-2.782.2
CFO To EBITDA
CFO To EBITDA%
3.7111.0-78.718.2-10.4-5.6-9.4-104.81.7-2.7-236.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
01-200000001
Investing Cash Flow
Investing Cash FlowCr
01000000000
Financing Cash Flow
Financing Cash FlowCr
00000000000
Net Cash Flow
Net Cash FlowCr
02-200000001
Free Cash Flow
Free Cash FlowCr
01-200000001
CFO To PAT
CFO To PAT%
5.598.2-120.415.8-12.9-6.0-11.4-36.62.1-2.782.2
CFO To EBITDA
CFO To EBITDA%
3.7111.0-78.718.2-10.4-5.6-9.4-104.81.7-2.7-236.9

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1421161167556567
Price To Earnings
Price To Earnings
14.514.812.68.49.56.67.6
Price To Sales
Price To Sales
0.30.30.30.20.10.20.60.20.40.40.40.4
Price To Book
Price To Book
2.53.02.11.30.60.80.70.81.21.41.41.5
EV To EBITDA
EV To EBITDA
9.615.28.09.17.1-10.4-2.5-14.9-3.7-2.6-18.3-13.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
13.613.412.110.012.09.422.312.611.39.713.913.9
OPM
OPM%
3.02.03.51.81.5-1.7-23.3-1.4-9.3-13.2-1.9-2.6
NPM
NPM%
2.02.32.32.01.2-1.6-19.1-3.9-7.6-12.95.54.9
ROCE
ROCE%
25.126.326.421.69.4-3.7-28.5-6.4-30.4-53.40.10.1
ROE
ROE%
17.220.116.815.46.4-6.3-22.8-13.8-24.6-51.821.721.7
ROA
ROA%
6.88.25.75.92.9-4.0-11.9-6.0-8.6-8.54.54.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1421161167556567
Price To Earnings
Price To Earnings
14.514.812.68.49.56.67.6
Price To Sales
Price To Sales
0.30.30.30.20.10.20.60.20.40.40.40.4
Price To Book
Price To Book
2.53.02.11.30.60.80.70.81.21.41.41.5
EV To EBITDA
EV To EBITDA
9.615.28.09.17.1-10.4-2.5-14.9-3.7-2.6-18.3-13.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
13.613.412.110.012.09.422.312.611.39.713.913.9
OPM
OPM%
3.02.03.51.81.5-1.7-23.3-1.4-9.3-13.2-1.9-2.6
NPM
NPM%
2.02.32.32.01.2-1.6-19.1-3.9-7.6-12.95.54.9
ROCE
ROCE%
25.126.326.421.69.4-3.7-28.5-6.4-30.4-53.40.10.1
ROE
ROE%
17.220.116.815.46.4-6.3-22.8-13.8-24.6-51.821.721.7
ROA
ROA%
6.88.25.75.92.9-4.0-11.9-6.0-8.6-8.54.54.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Brawn Biotech Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/xdlguieno5wb0ei01jks3add.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/76wq6i6set7y83s10mf8e82h.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/d8e9qjdvhevqyndev8w55tty.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/mtczr0fqhveyimzbfmdlsx66.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/eft4s99elyytca7o682rozwf.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/mi66e1tbkmlkxdt0qaxwju25.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/b480ko592tn5tgn4ox9a9dsj.pdf
  • Q4 FY2024 Quarterly Result (Mar 2024, PDF): https://www.stockscans.in/document/p4kif4byng63ukdvwjj4h2tc.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/j85bt1fc1f13imgavi4zqeib.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/gwil19qwt22fg1fukgymft33.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/4kk311tpqbm25wxezu2vn3lt.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/w3chfeaauc7nja2chaj6jj1i.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/97suxv529kyq71pll8fnrq27.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/1ibiujldq1tjgx0pyq5xn18w.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/zhw56thbzmiayjb3t8ghmp1c.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies